Last reviewed · How we verify

NCT03760926

A Trial of the May Health Device in Transvaginal Ablation of Ovarian Tissue Under ULTRAsound Visualization in Women With PCOS Infertility

Completed NA Last updated 27 August 2025
What this trial tests

NA trial testing May Health Kit in Polycystic Ovary Syndrome in 28 participants. Completed in 15 August 2025.

Timeline
14 February 2019
Primary endpoint
2 September 2023
15 August 2025

Quick facts

Lead sponsorMay Health
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposedevice feasibility
Enrollment28
Start date14 February 2019
Primary completion2 September 2023
Estimated completion15 August 2025
Sites6 locations across Belgium, France, United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

May Health — full company profile →

Who can join

Adults 18 to 40, female only, with Polycystic Ovary Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to provide preliminary evidence for the safety and effectiveness of the May Health Kit in transvaginal ablation of ovarian tissue under ultrasound visualization in women with infertility due to polycystic ovary syndrome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Polycystic Ovary Syndrome

Currently open trials in the same condition.

Other May Health trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03760926.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing